Detalles de la búsqueda
1.
Impact of Increasing PD-L1 Levels on Outcomes to PD-1/PD-L1 Inhibition in Patients With NSCLC: A Pooled Analysis of 11 Prospective Clinical Trials.
Oncologist
; 29(5): 422-430, 2024 May 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-38349736
2.
Accelerating pandemic response with the emergency Omicron RT-PCR test: A comprehensive solution for COVID-19 diagnosis and tracking.
J Med Virol
; 95(7): e28914, 2023 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-37394776
3.
Iatrogenic Abdominal Aortic Rupture During Transpedicular Bone Grafting for Thoracolumbar Burst Fractures Successfully Treated by Endovascular Stent Implantation.
J Endovasc Ther
; 30(5): 792-797, 2023 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-36927122
4.
Time to deterioration of symptoms or function using patient-reported outcomes in cancer trials.
Lancet Oncol
; 23(5): e229-e234, 2022 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-35489354
5.
Overall survival in patients with hormone receptor-positive, HER2-negative, advanced or metastatic breast cancer treated with a cyclin-dependent kinase 4/6 inhibitor plus fulvestrant: a US Food and Drug Administration pooled analysis.
Lancet Oncol
; 22(11): 1573-1581, 2021 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-34656225
6.
Survival outcomes in older men with non-metastatic castration-resistant prostate cancer treated with androgen receptor inhibitors: a US Food and Drug Administration pooled analysis of patient-level data from three randomised trials.
Lancet Oncol
; 22(9): 1230-1239, 2021 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-34310904
7.
FDA Approval Summary: Olaparib Monotherapy or in Combination with Bevacizumab for the Maintenance Treatment of Patients with Advanced Ovarian Cancer.
Oncologist
; 26(1): e164-e172, 2021 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33017510
8.
FDA Approval Summary: Rucaparib for the Treatment of Patients with Deleterious BRCA-Mutated Metastatic Castrate-Resistant Prostate Cancer.
Oncologist
; 26(2): 139-146, 2021 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-33145877
9.
Single-stage debridement via autogenous iliac bone graft through the OLIF corridor and lateral fixation in treating spontaneous single-level lumbar pyogenic spondylodiscitis.
BMC Musculoskelet Disord
; 22(1): 947, 2021 Nov 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-34781926
10.
Hypermethylation of SHISA3 DNA as a blood-based biomarker for colorectal cancer.
Chin J Physiol
; 64(1): 51-56, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-33642344
11.
Immune Response Evaluation and Treatment with Immune Checkpoint Inhibitors Beyond Clinical Progression: Response Assessments for Cancer Immunotherapy.
Curr Oncol Rep
; 22(11): 116, 2020 08 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-32851542
12.
U.S. Food and Drug Administration Benefit-Risk Assessment of Nilotinib Treatment Discontinuation in Patients with Chronic Phase Chronic Myeloid Leukemia in a Sustained Molecular Remission.
Oncologist
; 24(5): e188-e195, 2019 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-31019020
13.
FDA Approval Summary: Atezolizumab or Pembrolizumab for the Treatment of Patients with Advanced Urothelial Carcinoma Ineligible for Cisplatin-Containing Chemotherapy.
Oncologist
; 24(4): 563-569, 2019 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-30541754
14.
FDA Approval Summary: Nivolumab in Advanced Renal Cell Carcinoma After Anti-Angiogenic Therapy and Exploratory Predictive Biomarker Analysis.
Oncologist
; 22(3): 311-317, 2017 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-28232599
15.
FDA Approval Summary: Atezolizumab for the Treatment of Patients with Progressive Advanced Urothelial Carcinoma after Platinum-Containing Chemotherapy.
Oncologist
; 22(6): 743-749, 2017 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-28424325
16.
Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis.
Lancet
; 384(9938): 164-72, 2014 Jul 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-24529560
17.
U.S. Food and Drug Administration Approval Summary: Ramucirumab for the Treatment of Metastatic Non-Small Cell Lung Cancer Following Disease Progression On or After Platinum-Based Chemotherapy.
Oncologist
; 20(11): 1320-5, 2015 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-26446239
18.
U.S. Food and Drug Administration Approval Summary: Enzalutamide for the Treatment of Patients With Chemotherapy-Naïve Metastatic Castration-Resistant Prostate Cancer.
Oncologist
; 20(8): 960-6, 2015 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-26070917
19.
Repair of massively defected hemi-joints using demineralized osteoarticular allografts with protected cartilage.
J Mater Sci Mater Med
; 26(8): 227, 2015 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-26319778
20.
Multiconfigurational actinide nitrides assisted by double Möbius aromaticity.
Chem Sci
; 15(21): 8216-8226, 2024 May 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-38817572